More concerning but less common side effects include gallbladder problems , potential thyroid issues (a black box warning exists for medullary thyroid carcinoma risk in animal studies), and hair loss related to rapid weight loss rather than the medication itself
NEW ORAL GLP-1 Foundayo is now available as a once-daily oral pill FDA-approved oral GLP-1 Easy, once-daily pill ~11% average weight loss at 72 weeks in Phase 3 trials No injections or refrigeration needed Prescription & ongoing care through Healthspan 1 In Phase 3 trial of adults without diabetes taking the highest dose of Foundayo (orforglipron) alongside diet and exercise
GHK-Cu is a copper-binding tripeptide (Gly-His-Lys complexed with copper), one of the most studied peptides in skin, collagen and tissue-remodelling research
The weight loss results from both the Wegovy pill and injection are generally comparable, but there may be slight variations in the speed at which they produce results
Holland AJ, Whittington JE, Butler J, Webb T, Boer H, Clarke D : Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome
